Our VP, Lindsay Bealor Greenleaf, talks with Sarah Karlin-Smith about HHS’s OIG opinion on Novartis’ CAR-T
Our VP, Lindsay Bealor Greenleaf, talks with Sarah Karlin-Smith about HHS’s OIG opinion on Novartis’ CAR-T
Read the article here.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.